Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis
...tionforpf.org/cpf_accomplishments.php .
"While this study does not represent a cure, it IS a historic first step in treating PF, and is a shining
ray of hope for the thousands of patients suffering from this terrible disease," said Mishka Michon, Chief Executive Officer of the CPF.
"Unfortunat...
Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program
...5-50%. "Millions of people experiencing tremor symptoms currently have no objective means to determine whether or not they have Parkinson's Disease,"
ray L. Watts, MD, John N. Whitaker Professor and Chairman of the Department of Neurology, University of Alabama at Birmingham stated. "There is a clear...
Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO'08
...e with Kansas scientists at the University of Kansas Cancer
Center and elsewhere to perform cancer research not possible at their home
institutions.
ray Smilor, executive director of the Beyster Institute at the Rady
School of Management at the University of California at San Diego and a KBA
director, ...
OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
...lace.
Prior to joining OxyBand, Dr. Postel was the Director of Process
Engineering and Integration at dpiX, the world leader of sensor arrays for
X-
ray medical imaging, where among his other responsibilities, he lead the
engineering start-up of a $100 MM expansion facility in Colorado Springs,
support...
Heart Patients More Likely to Adopt Healthy Habits in 3-Year Program Led by Cardiac Rehabilitation Experts, Mayo Clinic Research Shows
...fesaving benefits modern medicine offers,
and spare patients the trauma and the expense of repeat surgeries and
hospitalizations, says lead researcher
ray Squires, Ph.D.
"Earlier studies indicate that under traditional approaches, most
patients don't comply with treatment recommendations, including tak...
Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
...The sites participating in the first stage of the POET-2 clinical trial
program are: 1) University of Alabama, Birmingham, AL, Principal
Investigator:
ray Watts, M.D.; 2) University of Arizona Medical Center,
Tucson, AZ, Principal Investigator: Scott Sherman, M.D.; 3) Cedars-Sinai
Medical Center, Los Ang...
DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects
...ef Executive Officer DATATRAK International, Inc. 440-443-0082 x 112
ray Merk Chief Financial Officer DATATRAK International, Inc. 440-443-0082 x 181
...
Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program
...ma, Birmingham trial site
under the direction of Principal Investigator Dr.
ray L. Watts, MD,
Professor and Chairman of the Department of Neurology.
ALTR...onitor disease progression and the effects of
emerging therapeutics."
Dr.
ray L. Watts, M.D. of University of Alabama -- Birmingham, Movement
Disorder Sp...
Research Documents Scalable Production, Survival Following
Engraftment and Positive Impact on Cardiac Function in Infarcted
Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for
Heart Failure
...l models of diabetes," said Anish Majumdar,
Ph.D., Geron's senior director of cell therapy research. This work
was performed in collaboration with Dr.
ray Rajotte and Dr. Greg
Korbutt at the University of Alberta.
Chondrocytes for Orthopedic Applications
Finally, Geron collaborators at the University...
Digital vs. Analog Mammography
...to create display "windows" for masses and calcifications.
The soft copy display provides a direct-view display of the digital image on cathode
ray tube (CRT) monitors or liquid crystal display (LCD), allowing for unlimited manipulation of the contrast and brightness of the image, including image ...